The highly conserved DNA-binding domains of A-, B- and c-Myb differ with respect to DNA-binding, phosphorylation and redox properties

Nucleic Acids Research

Volumn 29, Issue 17, 2001, Pages 3546-3556

  Bergholtz, Stine ^a   Andersen, Tor Øyvind ^a   Andersson, Kristin B ^a   Borrebæk, Jørgen ^a   Lüscher, Bernhard ^b   Gabrielsen, Odd S ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASEIN KINASE II; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYSTEINE; DNA; PROTEIN A MYB; PROTEIN B MYB; PROTEIN C MYB; PROTEIN KINASE; PROTEIN MYB; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING SITE; COMPLEX FORMATION; CONTROLLED STUDY; DISSOCIATION; DNA BINDING; ESCHERICHIA COLI; MOLECULAR RECOGNITION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN STABILITY; VERTEBRATE;

EID: 0035444467     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/29.17.3546     Document Type: Article

References (75)

1. One billion years of Myb
2. Molecular evolution of the Myb family of transcription factors: Evidence for polyphyletic origin
3. Myb and oncogenesis
4. The myb gene family in cell growth, differentiation and apoptosis
5. Expression of protooncogene c-myb in normal human hematopoietic cells
6. Expression of mouse c-myb during embryonic development
7. Diverse developing mouse lineages exhibit high-level c-Myb expression in immature cells and loss of expression upon differentiation
8. Murine A-myb: Evidence for differential splicing and tissue-specific expression
9. Mouse A-myb encodes a trans-activator and is expressed in mitotically active cells of the developing central nervous system, adult testis and B lymphocytes
10. Arrest of spermatogenesis and defective breast development in mice lacking A-myb
11. B-Myb: A key regulator of the cell cycle
12. B-Myb protein in cellular proliferation, transcription control, and cancer: Latest developments
13. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis
14. B-myb is required for inner cell mass formation at an early stage of development
15. Regulation of B-Myb activity by cyclin D1
16. B-Myb, a repressed trans-activating protein
17. Linking Myb to the cell cycle: Cyclin-dependent phosphorylation and regulation of A-Myb activity
18. Modulation of c-Myb-induced transcription activation by a phosphorylation site near the negative regulatory domain
19. Differential regulation of c-Myb-induced transcription activation by a phosphorylation site in the negative regulatory domain
20. Increased affinity of c-Myb for CBP after CBP-induced acetylation
21. Proposed structure for the DNA-binding domain of the Myb oncoprotein based on model building and mutational analysis
22. Specific DNA binding by c-Myb: Evidence for a double helix-turn-helix-related motif
23. Solution structure of a specific DNA complex of the Myb DNA-binding domain with cooperative recognition helices
24. The Myb oncoprotein: Regulating a regulator
25. Solution structure of a DNA-binding unit of Myb: A helix-turn-helix- related motif with conserved tryptophans forming a hydrophobic core
26. Comparison of the free and DNA-complexed forms of the DNA-binding domain from c-Myb
27. DNA and redox state induced conformational changes in the DNA-binding domain of the Myb oncoprotein
28. Secondary structure of the DNA-binding domain of the c-Myb oncoprotein in solution. A multidimensional double and triple heteronuclear NMR study
29. Myb-DNA recognition: Role of tryptophan residues and structural changes of the minimal DNA binding domain of c-Myb
30. Preliminary investigation of the interaction between the R2R3 DNA-binding domain of the oncoprotein and DNA fragments
31. Structure of the B-Myb DNA-binding domain in solution and evidence for multiple conformations in the region of repeat-2 involved in DNA binding: Implications for sequence-specific DNA binding by Myb proteins
32. Solution structure of the B-Myb DNA-binding domain: A possible role for conformational instability of the protein in DNA binding and control of gene expression
33. The cavity in the hydrophobic core of Myb DNA-binding domain is reserved for DNA recognition and trans-activation
34. Backbone dynamics of the c-Myb DNA-binding domain complexed with a specific DNA
35. Viral myb oncogene encodes a sequence-specific DNA-binding activity
36. Binding of the c-myb proto-oncogene product to the simian virus 40 enhancer stimulates transcription
37. Nucleotide preferences in sequence-specific recognition of DNA by c-myb protein
38. Extension of the DNA binding consensus of the chicken c-Myb and v-Myb proteins
39. Flexibility in the second half-site sequence recognised by the c-Myb R2 domain-In vitro and in vivo analysis
40. Two functionally distinct half sites in the DNA-recognition sequence of the Myb oncoprotein
41. DNA binding activity and transcriptional activator function of the human B-myb protein compared with c-MYB
42. The chicken A-myb protein is a transcriptional activator
43. The human A-myb protein is a strong activator of transcription
44. The Myb DNA-binding domain is highly conserved in Dictyostelium discoideum
45. Mutations in v-myb alter the differentiation of myelomonocytic cells transformed by the oncogene
46. Myb binding proteins: Regulators and cohorts in transformation
47. Myb DNA binding inhibited by phosphorylation at a site deleted during oncogenic activation
48. Casein kinase II phosphorylation site mutations in c-Myb affect DNA binding and transcriptional cooperativity with NF-M
49. Highly conserved features of DNA binding between two divergent members of the myb family of transcription factors
50. Oncogenic point mutations induce altered conformation, redox sensitivity, and DNA binding in the minimal DNA binding domain of avian myeloblastosis virus v-Myb
51. Nitric oxide (NO) disrupts specific DNA binding of the transcription factor c-Myb in vitro
52. Use of T7 RNA polymerase to direct expression of cloned genes
53. Protein-oligonucleotide interactions
54. The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene
55. Vectors for the expression and analysis of DNA-binding proteins in yeast
56. Studies on the transformation of intact yeast cells by the LiAc/SS-DNA/PEG procedure
57. A rapid permeabilization procedure for accurate quantitative determination of beta-galactosidase activity in yeast cells
58. Sequence selectivity of c-Myb in vivo. Resolution of a DNA target specificity paradox
59. Two regions in c-myb protooncogene product negatively regulating its DNA-binding activity
60. DNA-binding domain and recognition sequence of the yeast BAS1 protein, a divergent member of the Myb family of transcription factors
61. Regulation of c-Myb through protein phosphorylation and leucine zipper interactions
62. Use of an oriented peptide library to determine the optimal substrates of protein kinases
63. Regulation of transcription factors c-Myc, Max, and c-Myb by casein kinase II
64. DNA and redox state induced conformational changes in the DNA-binding domain of the Myb oncoprotein
65. Transcription regulation by murine B-myb is distinct from that by c-myb
66. Regulation of DNA binding activity and nuclear transport of B-Myb in Xenopus oocytes
67. Serial analysis of gene expression in non-small cell lung cancer
68. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays
69. Functional antagonism between members of the myb family: B-myb inhibits v-myb-induced gene activation
70. TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins
71. Functional domains of the human B-myb gene product
72. Activation of human B-MYB by cyclins
73. B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation
74. B-Myb and cyclin D1 mediate heat shock element dependent activation of the human HSP70 promoter
75. DNA inhibits the catalytic activity of the alpha subunit of protein kinase CK2